GLP-1 Prior Authorization and Insurance Denials: A Practical Guide
How prior authorization works for GLP-1 weight-loss drugs, why denials happen, and the practical steps you can take next.
Prior authorization is a step where your insurer must approve a GLP-1 medication before it will pay for it. For weight loss, many plans require documented criteria, may insist on step therapy, and still deny coverage. If that happens, you can appeal, request a peer-to-peer review, or choose a transparent cash-pay path instead.
What prior authorization actually is
Prior authorization (often shortened to PA) is a cost-control process. Before your pharmacy can fill a brand GLP-1 such as Wegovy or Zepbound, your physician submits paperwork showing the plan's criteria are met. The insurer then approves, denies, or asks for more information. Approval is not the same as a low copay, and a PA on file does not lock in coverage forever, since plans can re-review it each year.
- It applies to FDA-approved brand drugs that your insurer is being asked to pay for.
- It does not apply to a cash-pay prescription you fill yourself, because no insurer is involved.
Why GLP-1 denials are so common
Many employer plans simply exclude drugs prescribed for weight loss, even when they cover the same molecule for diabetes. When coverage does exist, insurers commonly attach hurdles, and missing any one of them is a frequent reason a request is denied.
Ready to start?
$199 Skeptics' Trial, see if it works for you
One month of medical-grade compounded semaglutide, the $119 doctor review, and a free B-12/lipotropic injection. No long-term commitment.
Start the 30-day trial- A minimum BMI threshold, sometimes with a required weight-related condition.
- Step therapy, meaning you must try and fail other approaches first.
- Proof of a supervised weight program or prior lifestyle attempts.
- Quantity limits, formulary exclusions, or a preference for one brand over another.
What to do after a denial
A denial is rarely the end of the road. Read the denial letter for the exact reason and the appeal deadline, then ask your prescriber to file an appeal that addresses that specific reason with supporting documentation. You can also request a peer-to-peer review, where your physician speaks directly with the plan's medical reviewer.
Appeals take time and are not guaranteed, so it helps to know your alternatives while you wait. At New Hope Weight Loss, our compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA. They are a separate, physician-supervised cash-pay option, not a substitute for a covered brand drug, so this is information to discuss with your physician rather than medical advice.
How a cash-pay path compares
Cash-pay sidesteps prior authorization entirely because there is no insurer to satisfy. With us, that means a flat $119 medical review, compounded semaglutide from $166 per month, and compounded tirzepatide from $233 per month, with no PA forms and no step-therapy gatekeeping. If you prefer to test the approach first, our $199 one-month Skeptics' Trial lets you start with a clear, predictable cost.
Whether you pursue an appeal, a cash-pay option, or both, the right move depends on your plan, your health history, and your goals, so review the specifics with a qualified clinician before deciding.
What you can start today at New Hope Weight Loss
After a one-time $119 medical review with Dr. Sharma, eligible patients begin physician-supervised compounded semaglutide from $166 a month or compounded tirzepatide from $233 a month, with a $199 one-month Skeptics' Trial. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality. In person in Orange County and by telehealth across California and additional states.
Frequently asked questions
What is prior authorization for a GLP-1?
It is a process where your insurer must approve a GLP-1 medication before agreeing to pay for it. Your physician submits documentation showing the plan's coverage criteria are met.
Why did my insurance deny my weight-loss GLP-1?
Common reasons include plan exclusions for weight-loss drugs, an unmet BMI threshold, step-therapy requirements, or quantity and formulary limits. Your denial letter should state the specific reason.
Can I appeal a GLP-1 denial?
Yes. Read the denial letter for the deadline and reason, then ask your prescriber to file an appeal addressing that reason, and consider requesting a peer-to-peer review with the plan's medical reviewer.
Does a cash-pay GLP-1 need prior authorization?
No. Cash-pay involves no insurer, so there is no prior authorization or step therapy. At New Hope Weight Loss this means a flat $119 medical review and transparent monthly pricing.
Is compounded semaglutide the same as a brand GLP-1?
No. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA. They are a separate option to discuss with your physician.
This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.